Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing MC-1 for the treatment o...
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 204 487 7412
Fax: 204 453 1370
Address:
2-1250 Waverley Street, Winnipeg, Canada
